Clinical Trials Directory

Trials / Conditions / Relapsed Adult ALL

Relapsed Adult ALL

7 registered clinical trials studyying Relapsed Adult ALL — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingBridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for
NCT06581081
Peking University People's HospitalN/A
UnknownPlerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT
NCT06141304
The First Hospital of Jilin UniversityPhase 2
UnknownThisCART19A Bridging to alloHSCT for R/R B-ALL
NCT05679687
The First Affiliated Hospital of Soochow UniversityPhase 1
RecruitingAnti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refra
NCT03938987
University of AlbertaPhase 1 / Phase 2
UnknownAnti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT
NCT04516551
Xinqiao Hospital of ChongqingPhase 1
Active Not RecruitingCD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
NCT03774654
Baylor College of MedicinePhase 1
UnknownAntiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Follow
NCT03091933
Ciusss de L'Est de l'Île de MontréalPhase 1 / Phase 2